Skip to main content

$0.003 -0.001 (-16.67%)

High

$0.00

Low

$0.00

Trades

1

Turnover

$54

Volume

21,427
30 June 2023 at 2:30pm
Register to track ADR and receive email alerts.
Subject
ADR Ann: Adherium Releases Next Gen Platform Integration Services

ADR Ann: Adherium appoints VP of Global Business Development

ADR Ann: Notification of cessation of securities - ADR

ADR Ann: Adherium submits US FDA application for Ellipta sensor

ADR Ann: Cleansing notice under s708A of the Corporations Act

ADR Ann: Final Director's Interest Notice - M McNamara

ADR Ann: Initial Director's Interest Notice - L Panaccio

ADR Ann: Half Yearly Report and Accounts

ADR Ann: Lou Panaccio joins Adherium Board - Matt McNamara steps down

ADR Ann: Application for quotation of securities - ADR

ADR Ann: Notification of cessation of securities - ADR

ADR Ann: US Respiratory RPM and RTM Reimbursement Rates

ADR Ann: Manufacturing started for physiological parameters sensors

ADR Ann: Quarterly Activities/Appendix 4C Cash Flow Report

ADR Ann: Adherium receives MHRA Registration confirmation

ADR Ann: Adherium receives $1.6m Australian R&D Tax Incentive

ADR Ann: Notification of cessation of securities - ADR

ADR Ann: U.S. Remote Therapeutic Monitoring Codes Finalised

ADR Ann: Update - Notification of buy-back - ADR

ADR Ann: Update - Notification of buy-back - ADR

ADR Ann: Change of Director's Interest Notice - G Baran

ADR Ann: Change of Director's Interest Notice - M McNamara

ADR Ann: Change of Director's Interest Notice - J Curnock Cook

ADR Ann: Change of Director's Interest Notice - W Hunter

ADR Ann: Change of Director's Interest Notice - B McHarrie

ADR Ann: Change of Director's Interest Notice - J Ward-Lilley

ADR Ann: Cleansing notice under s708A of the Corporations Act

ADR Ann: Notification of buy-back - ADR

ADR Ann: Change in substantial holding

ADR Ann: Application for quotation of securities - ADR

ADR Ann: Application for quotation of securities - ADR

ADR Ann: Update - Proposed issue of securities - ADR

ADR Ann: Proposed issue of securities - ADR

ADR Ann: Ceasing to be a substantial holder

ADR Ann: Quarterly Activities/Appendix 4C Cash Flow Report

ADR Ann: Results of Meeting

ADR Ann: CEO's Address to Shareholders

ADR Ann: Adherium appoints Robert Spurr as Interim CFO

ADR Ann: Adherium comments on proposed US CPT codes for RTM

ADR Ann: Notification of cessation of securities - ADR

ADR Ann: ADR receives AUS R&D Tax Incentive and Team Build Out Update

ADR Ann: Change in substantial holding

ADR Ann: Update - Notification of buy-back - ADR

ADR Ann: Update - Notification of buy-back - ADR

ADR Ann: Notice of Annual General Meeting/Proxy Form

ADR Ann: Adherium awarded US-based AZ clinical study supply contract

ADR Ann: Notification regarding unquoted securities - ADR

ADR Ann: Summary of Stock Appreciation Rights terms

ADR Ann: Application for quotation of securities - ADR

ADR Ann: Operations Updates as Ms Anne Bell Steps Down as CFO

Register to track ADR and receive email alerts.

Similar Companies

VHT